You might also like

More about Economics of Drug R

• Book details
• Synopsis
• Trending among others

You get 219 loyalty points

Book synopsis

The research is based upon my Wharton thesis, focuses on pharmaceutical R&D investment decision. It is organized into 1 theoretical chapter, 4 empirical chapters and 3 empirical appendices. Chapter2 develops a q-model framework for analyzing the determinants of pharmaceutical R&D investment. Chapters 3 and 4 test the capital market imperfections hypothesis using a variety of statistical methods. Chapter 5 builds upon this work and test the hypothesis that pharmaceutical price regulation diminishes incentives to invest in R&D. Finally, Chapter 6 employs a computer simulation model of pharmaceutical innovation and competition to study how price regulation in U.S. could affect R&D investment and innovation. Results reveal cash flows are an independent determinant of pharmaceutical R&D investment. Evidence was also uncovered suggesting pharmaceutical price regulation exerts a substantially negative influence on firm R&D investment intensity. Chapter Six obtains results consistent with those reported in Chapter Five, but given the simulation technique and investment strategy perspective numerous other results and findings were obtained.

Book details

Book category Books in English Medicine Other branches of medicine Pharmacology

• Full title: Economics of Drug R
• Subtitle: Price Regulation,Capital Market Imperfections and Strategic R
• Author: John A. Vernon
• Language: English
• Binding: Paperback
• Number of pages: 320
• EAN: 9783639095975
• ISBN: 3639095979
• ID: 06818645
• Publisher: VDM Verlag
• Weight: 472 g
• Dimensions: 229 × 152 × 18 mm
• Date of publishing: 15. March 2010

Trending among others

---

---

---